Information intended for UK healthcare professionals only. 

These videos have been funded through an arm’s-length sponsorship by Novo Nordisk Limited. Guidelines approached Novo Nordisk Limited to fund the production of these videos. Please see the bottom of the page for the full disclaimer.

Dr Hasan Chowhan—General Practitioner, Clinical chair of North East Essex CCG

Dr Helen Parretti—General Practitioner, Beccles Medical Centre

Dr Hasan Chowhan and Dr Helen Parretti —both expert members of the Guidelines algorithm ’Managing obesity in primary care’ (developed by a multidisciplinary expert panel [Tahrani et al.] with the support of an educational grant from Novo Nordisk Limited) answer key questions in these two short videos.

Dr Hasan Chowhan covers:

  • why was the guidance developed and who is it intended for?
  • what are the key points for primary care healthcare professionals?
  • what else does the algorithm cover?
  • providing some practical tips for local implementation.

 

 

Dr Helen Parretti covers:

  • why is this guidance on the management of obesity in primary care important for healthcare professionals?
  • a patient case study where the guidance was used, how it was implemented, and where referral was appropriate
  • how practices could implement the enhanced services specification.

 

 

View the Guidelines algorithm: ’Managing obesity in primary care
(developed by a multidisciplinary expert panel [Tahrani et al.] with the support of an educational grant from Novo Nordisk Limited)

 

View the Guidelines in Practice supplement: ’Overcoming challenges in managing obesity in primary care
(developed by Dr Helen Parretti and Dr Hasan Chowhan with the support of an educational grant from Novo Nordisk Limited)

 

These videos have been funded through an arm’s-length sponsorship by Novo Nordisk Limited. Guidelines approached Novo Nordisk Limited to fund the production of these videos. Novo Nordisk Limited has had no influence over the selection of the presenters or the content of these videos and has reviewed them for technical accuracy only and to ensure compliance with regulations. The sponsorship fee included an honorarium for the speakers, who were contracted and paid by MGP. The views and opinions of the presenters are not necessarily those of Novo Nordisk Limited, or of Guidelines, its publisher, advisers, or advertisers. No part of these videos may be reproduced in any form without the permission of the publisher.

 

Date of preparation: December 2021